Results for breakpoint criteria translation from English to Maltese

clinical breakpoint
valur tal-limitu kliniku

mic breakpoint (mg/l)
punt kritiku tal-mic (mg/l)

staphylococci inferred from the methicillin breakpoint
staphylococci inferita mill-breakpoint ta’ methicillin

therefore, no breakpoint for susceptibility is given.
għalhekk, ma tingħata l-ebda breakpoint għas-suxxettibbilità.

no breakpoint for brachyspira hyodysenteriae has been established.
l-ebda breakpoint għal brachyspira hyodysenteriae ma ġie stabbilit.

this breakpoint might be lower in antiretroviral combination therapy not including a boosted protease inhibitor.
dan il-breakpoint jista’ jkun iktar baxx f’terapija antiretrovirali kkombinata li ma tinkludix impeditur ta’ protease ibbustjat.

if antifungal susceptibility testing is available, the mic results may be interpreted using breakpoint criteria established by european committee on antimicrobial susceptibility testing (eucast).
jekk it-testijiet ta’ suxxettibilità għall- antifungali huma disponibbli, ir-riżultati tal-mic jistgħu jiġu interpretati bl-użu ta’ kriterji tal- breakpoint stabbiliti mill-kumitat ewropew dwar ittestjar ta’ suxxettibilità kontra l-mikrobi (eucast).

1 strains with mic values above the susceptible (s) breakpoint are rare, or not yet reported.
1 forom b’valuri ta’ mic ‘il fuq mil-breakpoint suxxettibbli (s) huma rari, jew għadhom ma ġewx irrappurtati.

they are for use only for species that have not been given a species-specific breakpoint and are not for use with species where interpretative criteria remain to be determined (gram-negative anaerobes).
huma għall- użu biss għall- ispeċi li ma ngħatawx punt kritiku speċifiku għall - ispeċi u mhux għall- użu fi speċi fejn kriterji ta ’ interpretazzjoni għadhom ma ġewx iddeterminati (anerobi negattivi għal gram).

resistant bacteria isolated from canine otitis before treatment against gentamicin (determined according to clsi guideline breakpoint ≥ 16 µg/ ml) were low:
0. 06- 16

eucast clinical mic breakpoints for moxifloxacin (31.01.2006):
punti kritiċi ta ’ mic kliniċi eucast għal moxifloxacin (31. 01. 2006):